Role of p38 mitogen-activated protein kinase and extracellular signal- regulated protein kinase kinase in adenosine A(2B) receptor-mediated interleukin-8 production in human mast cells

Molecular Pharmacology

Volumn 55, Issue 4, 1999, Pages 726-734

  Feoktistov, Igor ^a   Goldstein, Anna E ^a   Biaggioni, Italo ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE DERIVATIVE; CALCIUM ION; ENZYME INHIBITOR; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C; PROTEIN P21; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; CALCIUM CELL LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HYPOXIA; INFLAMMATION; MAST CELL; PRIORITY JOURNAL;

NON-PROGRAMMATIC;

ADENOSINE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; ENZYME ACTIVATION; HUMANS; INTERLEUKIN-8; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MAST CELLS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASES; RECEPTOR, ADENOSINE A2B; RECEPTORS, PURINERGIC P1; SIGNAL TRANSDUCTION; TYROSINE;

EID: 0032950479     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Arcaro A and Wymann MP (1993) Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: The role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem J 296:297-301.
2. 2B receptor. Mol Pharmacol 52:846-860.
3. Burack WR and Sturgill TW (1997) The activating dual phosphorylation of MAPK by MEK is nonprocessive. Biochemistry 36:5929-5933.
4. Chao TS, Byron KL, Lee KM, Villereal M and Rosner MR (1992) Activation of MAP kinases by calcium-dependent and calcium-independent pathways. Stimulation by thapsigargin and epidermal growth factor. J Biol Chem 267:19876-19883.
5. Church MK and Holgate ST (1986) Adenosine and asthma. Trends Pharmacol Sci 7:49-50.
6. Church MK and Hughes PJ (1985) Adenosine potentiates immunological histamine release from rat mast cells by a novel cyclic AMP-independent cell-surface action. Br J Pharmacol 85:3-5.
7. Cristalli G, Vittori S, Thompson RD, Padgett WL, Shi D, Daly JW and Olsson RA (1994) Inhibition of platelet aggregation by adenosine receptor agonists. Naunyn-Schmiedeberg's Arch Pharmacol 349:644-650.
8. 2 receptors. J Immunol 92:2201-2206.
9. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher, TF, Young PR and Lee JC (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-233.
10. Cushley MJ and Holgate ST (1985) Adenosine-induced bronchoconstriction in asthma: Role of mast cell-mediator release. J Allergy Clin Immunol 75:272-278.
11. de Rooij J and Bos JL (1997) Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14:623-625.
12. Dudley DT, Pang L, Decker SJ, Bridges AJ and Saltiel AR (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci 92:7686-7689.
13. 2+/calmodulin-sensitive tyrosine kinase. J Biol Chem 271:14169-14175.
14. 2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96:1979-1986.
15. 2B receptors. Pharmacol Rev 49:381-402.
16. 2B adenosine receptor subtypes. Biochem Pharmacol 55:627-633.
17. 2B receptors - a novel therapeutic target in asthma? Trends Pharmacol Sci 19:148-153
18. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
19. q-mediated mitogen-activated protein kinase activation. J Biol Chem 270:17148-17153.
20. ras and the Ras-binding domain of the human Raf-1 protein kinase. J Biol Chem 270:2901-2905.
21. 2a receptor to inhibition of the mitogen-activated protein kinase cascade in Chinese hamster ovary cells. Biochem J 316:81-86.
22. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
23. Li Z, Jiang Y, Ulevitch RJ and Han J (1996) The primary structure of p38 gamma: A new member of p38 group of MAP kinases. Biochem Biophys Res Commun 228:334-340.
24. Marais R, Light Y, Mason C, Paterson H, Olson MF and Marshall CJ (1998) Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 280:109-112.
25. Marquardt DL, Alongi JL and Walker LL (1996) The phosphatidylinositol 3-kinase inhibitor wortmannin blocks mast cell exocytosis but not IL-6 production. J Immunol 156:1942-1945.
26. Marquardt DL, Parker CW and Sullivan TJ (1978) Potentiation of mast cell mediator release by adenosine. J Immunol 120:871-878.
27. Marquardt DL, Walker LL and Heinemann S (1994) Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. J Immunol 152: 4508-4515.
28. Moriguchi T, Gotoh Y and Nishida E (1996) Roles of the MAP kinase cascade in vertebrates. Adv Pharmacol 36:121-137.
29. Nesbitt SA and Horton MA (1992) A nonradioactive biochemical characterization of membrane proteins using enhanced chemilumescence. Anal Biochem 206:267-272.
30. Pang L, Sawada T, Decker SJ and Saltiel AR (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270:13585-13588.
31. Peachell PT, MacGlashan DWJ, Lichtenstein LM and Schleimer RP (1988) Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol 140:571-579.
32. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ and Davis RJ (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and thre-onine. J Biol Chem 270:7420-7426.
33. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268:16887-16890.
34. Selvan RS, Butterfield JH and Krangel MS (1994) Expression of multiple chemokine genes by a human mast cell leukemia. J Biol Chem 269:13893-13898.
35. 2A-adenosine receptor in primary human endothelial cells. J Biol Chem 272:5792-5799.
36. Suzuki H, Takei M, Nakahata T and Fukamachi H (1998) Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of Fc epsilon RI. Biochem Biophys Res Commun 242:697-702.
37. 3 receptor expression and function in eosinophils Am J Resp Cell Mol Biol 16:531-537.
38. q-protein-coupled pathway. J Biol Chem 270:8984-8990.
39. White JR and Lee JC (1993) Effect of protein kinase inhibitors on IL-8/NAP-1 release from human umbilical vein endothelial cells. Agents Actions 39:C73-C76.
40. Zu YL, Qi J, Gilchrist A, Fernandez GA, Vazquez-Abad D, Kreutzer DL, Huang C K and Sha'afi RI (1998) p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation. J Immunol 160:1982-1989.